FDA Investigator Jeffrey J Ebersole
Jeffrey J Ebersole has conducted inspections on 27 sites in 1 countries as of 11 Jul 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
27
Last Inspection Date:
11 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jeffrey J Ebersole:
Addam S Reynolds,
Alberto A Viciedo,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Ana S Cabrera,
Annemarie B Randow,
Annemarie Bodnar,
Anthony M Criscuolo, Jr,
Barbara J Maulfair,
Barbara Jwilimczyk Macri,
Cary Greene,
Charles J Chacko,
Chiang Syin, PhD,
Christina N Maurino,
Daniel J Grabicki,
Devon Jenkins,
Douglas C Kovacs,
Dr. Sriram Subramaniam, PhD,
Edward D Mcdonald,
Emest F Bizjak,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Frederick F Razzaghi,
Gayle S Lawson,
Gianine E Delade,
Gianine E Tompkins,
Helen B Ricalde,
Helen Verdel,
Jason M Sluzynski,
Joy Rkozlowski Klena,
Juanita P Versace,
Karen E D'orazio,
Keith M Reilly,
Kelli F Dobilas,
Kerry A Kurdilla,
Kristina J Donohue,
Kristy A Zielny,
Laishan L Lam,
Lawrence R Johnson,
Li Li,
Lisa B Hall,
Margaret M Sands,
Marie T Falcone,
Marjorie D Schultz,
Melissa B Libby,
Merril E Racke,
Michael R Klapal,
Nancy L Rolli,
Nerizza B Guerin,
Nicholas A Violand,
Paul L Bellamy,
Philip F Istafanos, DMV, MS,
Regina T Brown,
Remache,
Richard H Penta,
Robert G Ruff,
Robert Sharpnack,
Rochelle K Kimmel,
Sarah Forney,
Schultz,
Sherri J Liu,
Sinai I Davis,
Susan M Halsted,
Tania E Garcia,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Toyin B Oladimeji,
Valerie C Reed,
Willy A Orantes
Jeffrey J Ebersole's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more